{"created_at":"Fri Jul 11 08:11:16 +0000 2014","id":487509414937505792,"id_str":"487509414937505792","text":"$IACI Looking for the next $ABBV $BTYA $AIG #newsletter http:\/\/t.co\/XL2FXNGKFa","source":"\u003ca href=\"https:\/\/mobile.twitter.com\" rel=\"nofollow\"\u003eMobile Web (M2)\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2475711553,"id_str":"2475711553","name":"Kristian Nissle","screen_name":"cihykyxukyse","location":"Birmingham","url":null,"description":"Main,  Future teen idol ... Evil tv specialist ;  ogetic social media scholar -","protected":false,"verified":false,"followers_count":543,"friends_count":716,"listed_count":3,"favourites_count":0,"statuses_count":461,"created_at":"Sat May 03 16:23:27 +0000 2014","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"8B542B","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme8\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme8\/bg.gif","profile_background_tile":false,"profile_link_color":"9D582E","profile_sidebar_border_color":"D9B17E","profile_sidebar_fill_color":"EADEAA","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/464581844067835904\/ZX2LdjIs_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/464581844067835904\/ZX2LdjIs_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"newsletter","indices":[44,55]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/XL2FXNGKFa","expanded_url":"http:\/\/bit.ly\/1s1AQkf","display_url":"bit.ly\/1s1AQkf","indices":[56,78]}],"user_mentions":[],"symbols":[{"text":"IACI","indices":[0,5]},{"text":"ABBV","indices":[27,32]},{"text":"BTYA","indices":[33,38]},{"text":"AIG","indices":[39,43]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jul 11 18:36:28 +0000 2014","id":487666751652388864,"id_str":"487666751652388864","text":"Shire, AbbVie met this week to discuss latest takeover proposal. $ABBV  http:\/\/t.co\/MCrZMiop3a via @WSJ $SHPG","source":"\u003ca href=\"https:\/\/dev.twitter.com\/docs\/tfw\" rel=\"nofollow\"\u003eTwitter for Websites\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":15563814,"id_str":"15563814","name":"Peter D. Loftus","screen_name":"Loftus","location":"Philadelphia","url":"http:\/\/online.wsj.com\/home-page","description":"Wall Street Journal @WSJ reporter covering pharmaceutical industry. Contact me at 215-881-7127, peter.loftus@wsj.com.","protected":false,"verified":true,"followers_count":6900,"friends_count":981,"listed_count":312,"favourites_count":12,"statuses_count":1281,"created_at":"Wed Jul 23 14:50:58 +0000 2008","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"0099B9","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme4\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme4\/bg.gif","profile_background_tile":false,"profile_link_color":"0099B9","profile_sidebar_border_color":"5ED4DC","profile_sidebar_fill_color":"95E8EC","profile_text_color":"3C3940","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/3603168220\/ec9231b3cb42071435989faf0f872614_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/3603168220\/ec9231b3cb42071435989faf0f872614_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/15563814\/1389970742","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/MCrZMiop3a","expanded_url":"http:\/\/on.wsj.com\/1wbxuIS","display_url":"on.wsj.com\/1wbxuIS","indices":[72,94]}],"user_mentions":[{"screen_name":"WSJ","name":"Wall Street Journal","id":3108351,"id_str":"3108351","indices":[99,103]}],"symbols":[{"text":"ABBV","indices":[65,70]},{"text":"SHPG","indices":[104,109]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jul 11 19:15:16 +0000 2014","id":487676515979911168,"id_str":"487676515979911168","text":"Shire Holding Takeover Talks With AbbVie. Come by and discuss |http:\/\/t.co\/cJJr1LB9dA @abbvie @AbbottNews $ABBV $ABT","source":"\u003ca href=\"http:\/\/bufferapp.com\" rel=\"nofollow\"\u003eBuffer\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1112225545,"id_str":"1112225545","name":"medtech[y]","screen_name":"medtechy","location":"Boston, MA","url":"http:\/\/medtechy.com","description":"Laser-focused on the unique needs of the medical sales industry, Medtech[y]'s ENTIRE mission is to simplify the life of medical sales pros. Debuting in 2014","protected":false,"verified":false,"followers_count":453,"friends_count":1955,"listed_count":0,"favourites_count":239,"statuses_count":1784,"created_at":"Tue Jan 22 18:03:44 +0000 2013","utc_offset":-18000,"time_zone":"Central Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/3663675804\/412f5180cf8d5f64900341d7f8e5861f_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/3663675804\/412f5180cf8d5f64900341d7f8e5861f_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/1112225545\/1398874635","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/cJJr1LB9dA","expanded_url":"http:\/\/bit.ly\/1m1hymQ","display_url":"bit.ly\/1m1hymQ","indices":[63,85]}],"user_mentions":[{"screen_name":"abbvie","name":"AbbVie","id":531892451,"id_str":"531892451","indices":[86,93]},{"screen_name":"AbbottNews","name":"Abbott","id":360054369,"id_str":"360054369","indices":[94,105]}],"symbols":[{"text":"ABBV","indices":[106,111]},{"text":"ABT","indices":[112,116]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jul 11 13:10:47 +0000 2014","id":487584790762094592,"id_str":"487584790762094592","text":"$ABBV: How Gilead Sciences Can Deliver A Double: Part Two http:\/\/t.co\/oaxwOZJaxG","source":"\u003ca href=\"http:\/\/stockratingreport.blogspot.com\" rel=\"nofollow\"\u003eSRRT\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1729162460,"id_str":"1729162460","name":"Market Headlines","screen_name":"VanMacher","location":"","url":null,"description":null,"protected":false,"verified":false,"followers_count":141,"friends_count":0,"listed_count":5,"favourites_count":0,"statuses_count":77916,"created_at":"Wed Sep 04 15:54:35 +0000 2013","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/486368774094721026\/TKu18ZCg_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/486368774094721026\/TKu18ZCg_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/oaxwOZJaxG","expanded_url":"http:\/\/stockratingreport.com\/i.php?http:\/\/www.forbes.com\/sites\/kenkam\/2014\/07\/11\/how-gilead-sciences-can-deliver-a-double-part-two-2\/&t6t=ABBV","display_url":"stockratingreport.com\/i.php?http:\/\/w\u2026","indices":[58,80]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[0,5]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
